, Department of Health and Human Services and National Institutes of Health, 2000.

M. Horneber, G. Bueschel, and D. Less, How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis, Integr Cancer Ther, vol.11, issue.3, pp.187-203, 2012.

S. R. Adler, Complementary and alternative medicine use among women with breast cancer, Med Anthropol Q, vol.13, issue.2, pp.214-236, 1999.

P. A. Ganz, K. A. Desmond, and B. Leedham, Quality of life in longterm, disease-free survivors of breast cancer: a follow-up study, J Natl Cancer Inst, vol.94, issue.1, pp.39-49, 2002.

D. Hunter, R. Oates, and J. Gawthrop, Complementary and alternative medicine use and disclosure amongst Australian radiotherapy patients, Support Care Cancer, vol.22, issue.6, pp.1571-1579, 2014.

I. Hyodo, N. Amano, and K. Eguchi, Nationwide survey on complementary and alternative medicine in cancer patients in Japan, J Clin Oncol, vol.23, issue.12, pp.2645-54, 2005.

A. Molassiotis, P. Fernadez-ortega, and D. Pud, Use of complementary and alternative medicine in cancer patients: a European survey, Ann Oncol, vol.16, issue.4, pp.655-63, 2005.

C. G. Pedersen, S. Christensen, and A. B. Jensen, Prevalence, sociodemographic and clinical predictors of post-diagnostic utilisation of different types of complementary and alternative medicine (CAM) in a nationwide cohort of Danish women treated for primary breast cancer, Eur J Cancer, vol.45, issue.18, pp.3172-81, 2009.

M. Baum, B. R. Cassileth, and R. Daniel, The role of complementary and alternative medicine in the management of early breast cancer: recommendations of the European Society of Mastology (EUSOMA), Eur J Cancer, vol.42, issue.12, pp.1711-1715, 2006.

G. E. Deng, S. M. Rausch, and L. W. Jones, Complementary therapies and integrative medicine in lung cancer: Diagnosis and management of lung cancer, Chest, vol.143, issue.5, 2013.

L. Simon, D. Prebay, and A. Beretz, Complementary and alternative medicines taken by cancer patients, Bull Cancer, vol.94, issue.5, pp.483-491, 2007.

S. Trager-maury, C. Tournigand, and F. Maindrault-goebel, Use of complementary medicine by cancer patients in a French oncology department, Bull Cancer, vol.94, issue.11, pp.1017-1042, 2007.

L. Huiart, A. D. Bouhnik, and D. Rey, Complementary or alternative medicine as possible determinant of decreased persistence to aromatase inhibitor therapy among older women with non-metastatic breast cancer, Plos One, vol.8, issue.12, p.81677, 2013.

A. Thomas-schoemann, J. Alexandre, and C. Mongaret, Use of antioxidant and other complementary medicine by patients treated by antitumor chemotherapy: a prospective study, Bull Cancer, vol.98, issue.6, pp.645-53, 2011.

A. D. Bouhnik, M. K. Bendiane, and . Cortaredona, The labour market, psychosocial outcomes and health conditions in cancer survivors: protocol for a nationwide longitudinal survey 2 and 5 years after cancer diagnosis (the VICAN survey), BMJ Open, vol.5, issue.3, p.5971, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01928073

J. N. Burdine, M. R. Felix, and A. L. Abel, The SF-12 as a population health measure: an exploratory examination of potential for application, Health Serv Res, vol.35, issue.4, pp.885-904, 2000.

M. Groenvold, M. C. Klee, and M. A. Sprangers, Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement, J Clin Epidemiol, vol.50, issue.4, pp.441-50, 1997.

R. Portenoy, Development and testing of a neuropathic pain screening questionnaire: ID Pain, Curr Med Res Opin, vol.22, issue.8, pp.1555-65, 2006.

D. Bouhassira, N. Attal, and H. Alchaar, Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4), Pain, vol.114, issue.1-2, pp.29-36, 2005.

P. Tuppin, . De-roquefeuil, and A. Weill, French national health insurance information system and the permanent beneficiaries sample, Rev Epidemiol Sante Publique, vol.58, issue.4, pp.286-90, 2010.

M. J. Horner, L. Ries, and M. Krapcho, Cancer Statistics Review, 1975.

J. L. Lanoë and Y. Makdessi-reynaud, L'état de santé en France en 2003: santé perçue, morbidité déclarée et recours aux soins à travers l'enquête décennale santé, Etudes et, vol.436, pp.1-12, 2005.

A. D. Bouhnik, M. Préau, and M. A. Schlitz, Unsafe sex with casual partners and quality of life among HIV-infected gay men: evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA), J Acquir Immune Defic Syndr, vol.42, issue.5, pp.597-603, 2006.
URL : https://hal.archives-ouvertes.fr/inserm-00108375

L. Corroller-soriano, A. G. Bouhnik, A. D. Preau, and M. , Does cancer survivors' health-related quality of life depend on cancer type? Findings from a large French national sample 2 years after cancer diagnosis, Eur J Cancer Care (Engl), vol.20, issue.1, pp.132-172, 2011.

M. Preau, F. Marcellin, and M. P. Carrieri, Health-related quality of life in French people living with HIV in 2003: results from the national ANRS-EN12-VESPA Study, AIDS, vol.21, issue.1, pp.19-27, 2007.
URL : https://hal.archives-ouvertes.fr/halshs-01563633

G. Maskarinec, C. C. Gotay, and Y. Tatsumura, Perceived cancer causes: use of complementary and alternative therapy, Cancer Pract, vol.9, issue.4, pp.183-90, 2001.

M. A. Richardson, T. Sanders, and J. L. Palmer, Complementary/ alternative medicine use in a comprehensive cancer center and the implications for oncology, J Clin Oncol, vol.18, issue.13, pp.2505-2519, 2000.

M. A. Navo, J. Phan, and C. Vaughan, An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies, J Clin Oncol, vol.22, issue.4, pp.671-77, 2004.

K. T. Morris, N. Johnson, L. Homer, and D. Walts, A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites, Am J Surg, vol.179, pp.407-418, 2000.

J. M. Bauml, C. J. Langer, and T. Evans, Does perceived control predict complementary and alternative medicine (CAM) use among patients with lung cancer? A cross-sectional survey, Support Care Cancer, vol.22, pp.2465-72, 2014.

J. M. Bauml, S. Chokshi, and M. M. Schapira, Do attitudes and beliefs regarding complementary and alternative medicine impact its use among patients with cancer? A Cross-Sectional Survey Cancer, vol.121, pp.2431-2439, 2015.
DOI : 10.1002/cncr.29173
URL : https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.29173

G. V. Edwards, N. J. Aherne, and P. J. Horsley, Prevalence of complementary and alternative therapy use by cancer patients undergoing radiation therapy, Asia Pac J Clin Oncol, vol.10, issue.4, pp.346-53, 2014.

K. Chrystal, S. Allan, and G. Forgeson, The use of complementary/ alternative medicine by cancer patients in a New Zealand regional cancer treatment centre, N Z Med J, vol.116, p.296, 1168.

E. Crocetti, N. Crotti, and A. Feltrin, The use of complementary therapies by breast cancer patients attending conventional treatment, Eur J Cancer, vol.34, issue.3, pp.324-332, 1998.

P. J. Smith, A. Clavarino, and J. Long, Why do some cancer patients receiving chemotherapy choose to take complementary and alternative medicines and what are the risks?, Asia Pac J Clin Oncol, vol.10, issue.1, pp.1-10, 2014.
DOI : 10.1111/ajco.12115
URL : https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.12115

S. G. Kim, E. C. Park, and J. H. Park, Initiation and discontinuation of complementary therapy among cancer patients, J Clin Oncol, vol.25, issue.33, pp.5267-74, 2007.
DOI : 10.1200/jco.2007.11.9651
URL : http://hwmaint.jco.ascopubs.org/cgi/reprint/25/33/5267.pdf

H. J. Burstein, S. Gelber, and E. Guadagnoli, Use of alternative medicine by women with early-stage breast cancer, N Engl J Med, vol.340, issue.22, pp.1733-1742, 1999.
DOI : 10.1056/nejm199906033402206

M. Carlsson, M. Arman, and M. Backman, Perceived quality of life and coping for Swedish women with breast cancer who choose complementary medicine, Cancer Nurs, vol.24, issue.5, pp.395-401, 2001.

H. Boon, M. Stewart, and M. A. Kennard, Use of complementary/ alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions, J Clin Oncol, vol.18, issue.13, pp.2515-2536, 2000.

P. Cohen, A. Sarradon-eck, and O. Schmitz, Cancer et pluralisme thérapeutique: Enquête auprès des malades et des institutions médicales en France, L'Harmattan, 2016.

M. Bury, Chronic illness as biographical disruption, Sociol Healt Ill, vol.4, issue.2, pp.167-82, 1982.
DOI : 10.2307/j.ctt1t895q0.11

J. A. Astin, Why patients use alternative medicine: results of a national study, JAMA, vol.279, pp.1548-53, 1998.

T. C. Clarke, L. I. Black, and B. J. Stussman, Trends in the use of complementary health approaches among adults: United States, National Health Statistices Reports, issue.79, 2002.

J. M. Chan, E. P. Elkin, and S. J. Silva, Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer, Urology, vol.66, issue.6, pp.1223-1231, 2005.

D. M. Eisenberg, R. B. Davis, and S. L. Ettner, Trends in alternative medicine use in the United States, 1990-1997: results of a followup national survey, JAMA, vol.280, issue.18, pp.1569-75, 1998.

D. M. Eisenberg, R. C. Kessler, and C. Foster, Unconventional medicine in the United States. Prevalence, costs, and patterns of use, N Engl J Med, vol.328, issue.4, pp.246-52, 1993.

E. Ernst, Prevalence of use of complementary/alternative medicine: a systematic review, Bull World Health Organ, vol.78, issue.2, pp.252-259, 2000.

M. Kelner and B. Wellman, Health care and consumer choice: medical and alternative therapies, Soc Sci Med, vol.45, issue.2, pp.203-215, 1997.
DOI : 10.1016/s0277-9536(96)00334-6

J. Kersnik, Predictive characteristics of users of alternative medicine, Schweiz Med Wochenschr, vol.130, issue.11, pp.390-394, 2000.

R. C. Kessler, R. B. Davis, and D. F. Foster, Long-term trends in the use of complementary and alternative medical therapies in the United States, Ann Intern Med, vol.135, issue.4, pp.262-270, 2001.

M. M. Lee, S. S. Lin, and M. R. Wrensch, Alternative therapies used by women with breast cancer in four ethnic populations, J Natl Cancer Inst, vol.92, issue.1, pp.42-49, 2000.

P. Elziere, Des médecines dites naturelles, Sciences Sociales et Santé, vol.IV, issue.2, pp.39-74, 1986.

F. Laplantine and P. L. Rabeyron, , 1987.

L. G. Balneaves, T. L. Truant, and M. Kelly, Bridging the gap: decision-making processes of women with breast cancer using complementary and alternative medicine (CAM). Support Care Cancer, vol.15, pp.973-83, 2007.

L. Baider, E. Andritsch, and B. Uziely, Effects of age on coping and psychological distress in women diagnosed with breast cancer: review of literature and analysis of two different geographical settings, Crit Rev Oncol Hematol, vol.46, issue.1, pp.5-16, 2003.

A. J. Bartman and K. A. Roberto, Coping strategies of middle-aged and older women who have undergone a mastectomy, J Appl Gerontol, vol.15, issue.3, pp.376-86, 1996.

S. Gozum, A. Tezel, and K. Koc, Complementary alternative treatments used by patients with cancer in eastern Turkey, Cancer Nurs, vol.26, issue.3, pp.230-236, 2003.

B. R. Cassileth, Unorthodox cancer medicine, Cancer Invest, vol.4, issue.6, pp.591-599, 1986.

T. F. Hack, . Degner, and D. G. Dyck, Relationship between preferences for decisional control and illness information among women with breast cancer: a quantitative and qualitative analysis, Soc Sci Med, vol.39, issue.2, pp.279-89, 1994.

J. C. Holland, Why patients seek unproven cancer remedies: a psychological perspective, CA Cancer J Clin, vol.32, issue.1, pp.10-14, 1982.

K. J. Mcgregor and E. R. Peay, The choice of alternative therapy for health care: testingsome propositions, Soc Sci Med, vol.43, issue.9, pp.1317-1344, 1996.

M. J. Montbriand, Abandoning biomedicine for alternate therapies: oncology patients' stories, Cancer Nurs, vol.21, issue.1, pp.36-45, 1998.

W. Sollner, S. Maislinger, D. Vries, and A. , Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior, Cancer, vol.89, issue.4, pp.873-80, 2000.

T. Truant and J. L. Bottorff, Decision making related to complementary therapies: a process of regaining control, Patient Educ Couns, vol.38, issue.2, pp.131-173, 1999.

P. M. Yates, G. Beadle, and A. Clavarino, Patients with terminal cancer who use alternative therapies: their beliefs and practices, Sociol Health Illn, vol.15, issue.2, pp.199-216, 1993.

A. J. Zaloznik, Unproven (unorthodox) cancer treatments: a guide for healthcare professionals, Cancer Pract, vol.2, issue.1, pp.19-24, 1994.

T. Risberg, E. Lund, and E. Wist, Cancer patients use of nonproven therapy: a 5-year follow-up study, J Clin Oncol, vol.16, issue.1, pp.6-12, 1998.

C. Vincent and A. Furnham, Why do patients turn to complementary medicine? An empirical study, Br J Clin Psychol, vol.35, issue.1, pp.37-48, 1996.

A. C. Begot, Médecines parallèles et cancer: Une étude sociologique. Paris: L'Harmattan, 2010.